NCT03731923 - Abbreviated MRI for HCC Surveillance | Biotech Hunter

Enrollment

257

Participants

Timeline

Start Date

November 8, 2018

Primary Completion Date

December 15, 2021

Study Completion Date

December 31, 2023

Conditions

Hepatocellular CarcinomaLiver CirrhosisChronic Hepatitis

Interventions

DIAGNOSTIC_TEST

Biannual ultrasonography

Biannual liver ultrasonography for HCC surveillance, without contrast agent.

DIAGNOSTIC_TEST

Annual abbreviated liver MRI

Abbreviated liver MRI using standard dose of extracellular contrast agent (Dotarem, Guerbet, France) on weight-based dosing. Table time targets 10 minutes.

Trial Locations (2)

Unknown

Seoul National University Hospital, Seoul

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul